United StatesHouse Bill 4139HR 4139

Cutting Copays Act

Health

3 pages

house
senate
president

Last progress June 25, 2025 (5 months ago)

Introduced on June 25, 2025 by Morgan McGarvey

Sponsors (2)

House Votes

Pending Committee

June 25, 2025 (5 months ago)

Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Senate Votes

Vote Data Not Available

This bill lowers out-of-pocket costs for the lowest‑income people on Medicare’s Part D drug plans. Before 2026, it keeps very low copays ($1 for most generics and $3 for other drugs). Starting in 2026, generic drugs would have a $0 copay. Copays for other (mostly brand‑name) drugs would stay at the 2023 reduced level and then rise slightly each year with inflation. A summary also confirms that cost‑sharing for generics is eliminated for the lowest‑income group beginning in 2026.

Key points:

Who is affected: People with the lowest incomes who get the Medicare Part D Low‑Income Subsidy (Extra Help).
What changes: Copays drop to $0 for generics in 2026; reduced copays for other drugs are held at 2023 levels and then adjusted yearly for inflation; before 2026, copays are $1 for most generics and $3 for other drugs.
When: Changes start in 2026, with prior‑year limits continuing until then.

Cutting Copays Act

Sponsors (2)

House Votes

Senate Votes

Presidential Signature

AI Summary

Text Versions

Amendments